Brief: scPharmaceuticals Q4 Revenue USD 6.096 Million Vs. IBES Estimate USD 5.53 Million
Mar 13 (Reuters) - scPharmaceuticals Q4 net income USD -13.812 million. * Q4 basic EPS USD -0.35 * Q4 income from operations USD -15.257 million * Q4 operating expenses USD 21.353 million